SNTI earnings: real EPS beat/miss history, analyst consensus Buy, P/E -0.23. Updated 2026-07-23.
Senti Biosciences (SNTI) Research Hub
Senti Biosciences (SNTI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.306 USD (+2.34%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.23, market cap 0.01B. This hub links to the full technical, earnings and options research available for SNTI.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.306 USD (+2.34%) |
| 52-week range | 0.29 USD – 1.15 USD |
| Trend regime | Range |
| 14-day RSI | 41.7 (Bearish) |
| Trailing P/E | -0.23 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
Available research for SNTI
Covered Call on SNTI: how it works, illustrative setup around the real 0.306 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SNTI: how it works, illustrative setup around the real 0.306 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SNTI: how it works, illustrative setup around the real 0.306 USD price, max profit/loss, breakeven and when to use it. Educational.
SNTI technical analysis: range, last 0.306 USD, RSI 41.7, 52w range 0.29 USD–1.15 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SNTI in?
Senti Biosciences (SNTI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SNTI in an uptrend or downtrend?
As of 2026-09-11, SNTI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SNTI's trailing P/E ratio?
SNTI's trailing P/E is -0.23, with a market cap of 0.01B. See the earnings research page for full valuation detail.